BMS-986156, Ipilimumab, and Nivolumab With or Without Stereotactic Body Radiation Therapy in Treating Patients With Advanced or Metastatic Lung/Chest or Liver Cancers

Conditions:   Advanced Malignant Solid Neoplasm;   Metastatic Carcinoma in the Liver;   Metastatic Carcinoma in the Lung;   Metastatic Malignant Neoplasm in the Thoracic Cavity;   Metastatic Malignant Solid Neoplasm Interventions:   Drug: Anti-GITR Agonistic Monoclonal Antibody BMS-986156;   Biological: Ipilimumab;   Biological: Nivolumab;   Radiation: Stereotactic Body Radiation Therapy Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials